Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

JUN 13, 2013 - Benzinga

A Must Read - Share

FDA Issues Approval for Xgeva, Marketed by Amgen

The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor. GCTB generally occurs in adults between the ages of 20 and 40 years.

Tags: FDA Issues Approval for Xgeva, Marketed by Amgen,  Amgen Latest News